Association Between Grade(B/C)of Stage III and IV Periodontitis and High Sensitivity C Reactive Protein Level in Serum and Oral Rinse Sample
Association Between Grade (B/C)of Stage III and Stage IV Periodontitis and High Sensitivity C Reactive Protein Levels in Serum and Oral Rinse Sample :A Cross Sectional Study
1 other identifier
observational
87
1 country
1
Brief Summary
According to 2017 World Workshop of Periodontology , the level of high sensitivity C reactive protein has been assumed to increase according to the grade of periodontitis, however, specific evidence regarding this is lacking at present. Hence, measuring high sensitivity C reactive protein in serum and oral rinse samples in systemically healthy individuals with periodontitis could be potentially useful in gaining insight on the systemic burden of periodontal disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 12, 2025
CompletedFirst Posted
Study publicly available on registry
May 30, 2025
CompletedStudy Start
First participant enrolled
June 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 25, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 25, 2026
May 30, 2025
May 1, 2025
1 year
May 12, 2025
May 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation of hscrp level in oral rinse samples and serum in 3 groups of systemically healthy individuals
Evaluation of hsCRP level in oral rinse samples and serum in 3 groups of systemically healthy individuals (periodontally healthy, stage III and stage IV grade B generalized periodontitis, stage III and stage IV grade C generalized periodontitis)
12-14 months
Secondary Outcomes (2)
Correlation of Probing pocket depth (PPD)and Clinical attachment level (CAL) with level of hsCRP in oral rinse and serum samples.
12-14 months
Correlation of Bleeding on probing (BOP%)
12-14 months
Study Arms (3)
generalized periodontitis STAGE III/IV , Grade B
29 systemically healthy individuals With stage III /IV and grade B
generalized periodontitis STAGE III/IV , Grade C
29 systemically healthy individuals With stage III /IV and grade C
Periodontally healthy individuals
29 systemically and periodontally healthy individuals
Eligibility Criteria
1. Group 1: comprising of periodontally healthy individuals. 2. Group 2: comprising of individuals, diagnosed with stage III and stage IV grade B periodontitis (according to WWP 2017 classification periodontal disease ) 3. Group 3: comprising of participants, diagnosed with stage III and IV grade C periodontitis,
You may qualify if:
- Patients in the age group of (18-50 years)
- Presence of ≥ 20 natural teeth
- Ability and willingness to give written informed consent
- Patients belonging to 3 groups -periodontally healthy, stage III and stage IV grade B periodontitis, and stage III and stage IV grade C periodontitis .
You may not qualify if:
- Patients with chronic inflammatory disease such as nephrotic syndrome, chronic renal failure, significant cardiovascular disease, established type 1 or type 2 diabetes mellitus, or active cancer within the past 5 years
- Smokers and alcoholics
- Pregnant females
- Presence of xerostomia
- Patients undergoing radiotherapy
- Having received professional periodontal treatment within the previous 6 months
- Having received antibiotic medication 3 months prior to study
- Periapical pathology or other oral inflammatory conditions
- Cognitive disability (interfering with ability to give sample)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
PGIDS
Rohtak, Haryana, 124001, India
Study Officials
- PRINCIPAL INVESTIGATOR
Dr Aditi Sangwan, MDS
PGIDS ,ROHTAK
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 12, 2025
First Posted
May 30, 2025
Study Start
June 25, 2025
Primary Completion (Estimated)
June 25, 2026
Study Completion (Estimated)
August 25, 2026
Last Updated
May 30, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share